RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.07 BRL | -0.12% |
|
-0.44% | -14.73% |
| 05-08 | Transcript : Raia Drogasil S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| 05-07 | Raia Drogasil S.A. acquired remaining 15% stake in 4Bio Medicamentos S.A. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 39.18B 7.3B 573B | Sales 2025 * | 44.86B 8.36B 656B | Capitalization | 43.05B 8.02B 630B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.37B 256M 20.07B | Net income 2025 * | 1.78B 333M 26.11B | EV / Sales 2024 * | 1.28 x |
| Net Debt 2024 * | 7.17B 1.34B 105B | Net Debt 2025 * | 7.71B 1.44B 113B | EV / Sales 2025 * | 1.13 x |
| P/E ratio 2024 * |
31
x | P/E ratio 2025 * |
22.9
x | Employees | 57,708 |
| Yield 2024 * |
1.07% | Yield 2025 * |
1.85% | Free-Float | 74.06% |
More Fundamentals
* Assessed data
More news
Latest transcript on Raia Drogasil S.A.
More press releases
| 1 day | -0.12% | ||
| 1 week | -0.44% | ||
| 1 month | -2.26% | ||
| 3 months | -4.89% | ||
| 6 months | -11.26% | ||
| Current year | -14.73% |
1 week
24.57
25.73
1 month
24.5728.04
Current year
24.3029.87
1 year
24.3030.15
3 years
17.1430.15
5 years
13.9030.15
10 years
3.4830.15
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 30/06/13 | |
| Director of Finance/CFO | 61 | 28/04/13 | |
| Investor Relations Contact | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 23/11/11 | |
| Director/Board Member | 72 | 28/04/13 | |
| Director/Board Member | 46 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.01% | 17 M€ | -8.09% | - | |
| 1.35% | 12 M€ | +15.09% | - | |
| 1.21% | 14 M€ | -6.91% | ||
| 1.19% | 0 M€ | -6.18% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/24 | 25.07 | -0.12% | 4,037,700 |
| 10/06/24 | 25.1 | -0.87% | 2,494,900 |
| 07/06/24 | 25.32 | +0.76% | 6,112,000 |
| 06/06/24 | 25.13 | +0.72% | 4,517,200 |
| 05/06/24 | 24.95 | -0.91% | 4,225,200 |
Delayed Quote Sao Paulo, June 11, 2024 at 10:57 pm
More quotes
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
05/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.07
BRL
Average target price
30.5
BRL
Spread / Average Target
+21.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.73% | 8.04B | |
| +23.67% | 1.29B | |
| -14.42% | 338M | |
| -0.36% | 266M | |
| +10.56% | 225M | |
| -37.70% | 96.06M | |
| -15.60% | 80.97M | |
| +28.41% | 63.3M |
- Stock Market
- Equities
- RADL3 Stock